Tumor Regression After Treatment With Lenvatinib in <i>FGFR2</i>-Mutated Ameloblastoma
Alice N. Weaver, Frantz Francisque, Daniel W. Bowles
Abstract
First Page
Topics & Concepts
AmeloblastomaLenvatinibOncologyCancer researchMedicineBiologyInternal medicineCancerDentistryThyroid cancerMaxillaOral and Maxillofacial PathologyCancer Diagnosis and TreatmentBone Tumor Diagnosis and Treatments